These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11832492

  • 1. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
    Pediaditakis P, Monga SP, Mars WM, Michalopoulos GK.
    J Biol Chem; 2002 Apr 19; 277(16):14109-15. PubMed ID: 11832492
    [Abstract] [Full Text] [Related]

  • 2. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
    Niemann HH.
    Biochim Biophys Acta; 2013 Oct 19; 1834(10):2195-204. PubMed ID: 23123275
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity.
    Cioce V, Csaky KG, Chan AM, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS.
    J Biol Chem; 1996 May 31; 271(22):13110-5. PubMed ID: 8662798
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
    Chirgadze DY, Hepple J, Byrd RA, Sowdhamini R, Blundell TL, Gherardi E.
    FEBS Lett; 1998 Jun 23; 430(1-2):126-9. PubMed ID: 9678607
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R, Soriano JV, Malinda KM, Ponce ML, Bafico A, Kleinman HK, Bottaro DP, Aaronson SA.
    Cell Growth Differ; 1998 May 23; 9(5):355-65. PubMed ID: 9607557
    [Abstract] [Full Text] [Related]

  • 8. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.
    Jakubczak JL, LaRochelle WJ, Merlino G.
    Mol Cell Biol; 1998 Mar 23; 18(3):1275-83. PubMed ID: 9488442
    [Abstract] [Full Text] [Related]

  • 9. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
    Chirgadze DY, Hepple JP, Zhou H, Byrd RA, Blundell TL, Gherardi E.
    Nat Struct Biol; 1999 Jan 23; 6(1):72-9. PubMed ID: 9886295
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
    Gherardi E, Hartmann G, Hepple J, Chirgadze D, Srinivasan N, Blundell T.
    Ciba Found Symp; 1997 Jan 23; 212():84-93; discussion 93-104. PubMed ID: 9524765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
    Hartmann G, Prospero T, Brinkmann V, Ozcelik C, Winter G, Hepple J, Batley S, Bladt F, Sachs M, Birchmeier C, Birchmeier W, Gherardi E.
    Curr Biol; 1998 Jan 29; 8(3):125-34. PubMed ID: 9443912
    [Abstract] [Full Text] [Related]

  • 15. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS.
    J Biol Chem; 1997 Apr 04; 272(14):9457-63. PubMed ID: 9083085
    [Abstract] [Full Text] [Related]

  • 16. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
    Gherardi E, Sandin S, Petoukhov MV, Finch J, Youles ME, Ofverstedt LG, Miguel RN, Blundell TL, Vande Woude GF, Skoglund U, Svergun DI.
    Proc Natl Acad Sci U S A; 2006 Mar 14; 103(11):4046-51. PubMed ID: 16537482
    [Abstract] [Full Text] [Related]

  • 17. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Mar 14; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 18. Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist.
    Youles M, Holmes O, Petoukhov MV, Nessen MA, Stivala S, Svergun DI, Gherardi E.
    J Mol Biol; 2008 Mar 28; 377(3):616-22. PubMed ID: 18291418
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
    Ultsch M, Lokker NA, Godowski PJ, de Vos AM.
    Structure; 1998 Nov 15; 6(11):1383-93. PubMed ID: 9817840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.